Home |  Contact Us | Site Map

Investor Relations

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.

Recent Releases

Nov 19, 2009
BioCryst Announces Pricing of Public Offering of Common Stock

Nov 17, 2009
BioCryst Announces Proposed Public Offering of Common Stock

View all releases »

Investor Relations

Rob Bennett, Executive Director of Business Development & Investor Relations
919.859.7910
investorrelations@biocryst.com

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Co.
59 Maiden Lane
New York, New York 10038
Phone (718) 921-8247

Stock Information
NASDAQ : BCRX
$9.55   - 0.85
Nov 20, 2009
4:06 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.